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Coronary artery diseaseCoronary artery spasm (CAS) refers to the spontaneous or stimuli-induced transient, often localized and intense
subtotal or total constriction/occlusion of the epicardial coronary artery, usually concomitantwith angina pectoris
with associated elevation of the ST segment on electrocardiogram (ECG).
In this article, we present a literature review on post-valvular surgery CAS and report the clinical case of a
77 year-old man who experienced severe early post-aortic surgery chest pain and hemodynamic instability.
Emergent coronary angiography revealed severe occlusion of multiple branches of both coronary arteries. The
CAS was alleviated with intracoronary infusion of nitroglycerin.
© 2016 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Coronary artery spasm (CAS) refers to the spontaneous or stimuli-
induced transient, often localized and intense subtotal constriction or
total occlusion of the epicardial coronary artery, often concomitant with
angina pectoriswith resultant ST segment alteration on the electrocardio-
gram (ECG). Postoperative, or more speciﬁcally, post-valvular surgery
CAS is a multi-factorial, infrequent but lethal complication of open heart
surgery, with documented implication in perioperative cases of angina
pectoris, acute myocardial infarction and their associated hemodynamic
instability [1,2].
With a multi-factorial mechanistic underlining, there is no universal
prophylactic or deﬁnitive treatment, thus the adoption of diverse thera-
peutic approaches in preventing and/or alleviating post-valvular surgery
CAS, including cardiorespiratory inotrope support, intracoronary or intra-
venous administration of nitrates, non-steroidal anti-inﬂammatory
drugs, calcium pump blockers, phosphodiesterase inhibitors and adeno-
sine triphosphate (ATP), as well as initiation of intra-aortic balloon
pump (IABP) [2–5].
In the light of the undeﬁned incidence of post-valvular surgery CAS,
its critical role in the pathogenesis of perioperative coronary artery
disease (CAD), or so called ischemic heart disease (IHD), and post-
valvular surgery mortality, as well as the dearth of a documented
globally-consensual therapy guideline, we herein review currenta, Clinica Cardiochirurgica, A.O.
ormica).
land Ltd. This is an open access articlliterature on this subject (Table 1) and report a clinical case of multi-
vessel CAS after aortic valve replacement in our facility.
2. Case report
A 77-year-old man, known tobacco smoker with a history of hyper-
tension, aortic aneurysm of unspeciﬁed site without mention of rupture,
severe aortic valve insufﬁciency and coronary atherosclerosis of the na-
tive coronary artery, underwent replacement of the ascending aorta, aor-
tic valve annuloplasty with reconstruction of the sinotubular junction
(Florida sleeve technique) and coronary artery vein graft on obtuse mar-
ginal branch at our facility. Preoperative coronary angiography showed
no abnormal lesions (Fig. 1). There was intraoperative conﬁrmation
that the aortic valve and the free tricuspid edges were not thickened
with ﬁbro-calciﬁed lesions. Aortic root remodelling plus myocardial re-
vascularizationwas successfully performed. Immediate postoperative pe-
riod in the critical care unit was uneventful with the patient showing
regular sinus rhythm, no ischemic changeswith good left ventricular con-
tractility (Fig. 2).
Several hours later, in the night of the postoperative day 1 (1PO), the
intensive care unit critical (ICU) ECG alarm was triggered. ECG ﬁndings
included a recurring transient 2.5 mm ST segment elevation in the
anterior leads V3, V4 with similar elevation in the inferior leads II, III,
aVF (Fig. 3) which initially was non-responsive to intravenous vasodila-
tors therapy. In addition, there was hemodynamic instability but no
ventricular arrhythmia, prompting the diagnosis of postoperative
vasospasmic syndrome. We noted however that patient presented with
no excruciating chest pain with progressive dyspnoea, as is classicallye under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Review of current English language literature on post-valvular surgery coronary artery spasm.
No. Author(s) Year Diagnosis Study type Note
1 Alizadeh-Ghavidel
A, et al.
2015 CAS following aortic valve replacement Case report Focal RCA lesion, relieved by intracoronary nitrates infusion
2 Pragliola C, et al. 2015 CAS after mitral valve replacement Case report Focal RCA lesion, intracoronary injection of nitrates
3 Anselmi A, et al. 2013 CAS after tricuspid valve surgery Case report Diffuse CAS, intracoronary injection of nitrates
4 Tzeng SS, et al. 2012 Bead-like CAS Imaging Diffuse CAS, treated with nitrates and aspirin
5 Casquero E, et al. 2009 CAS after mitral and tricuspid annuloplasty Imaging Diffuse CAS, stabilized with intracoronary nitroglycerine and IABP
6 Pinho T, et al. 2007 CAS following aortic valve replacement Case report Focal RCA lesion, relieved with intracoronary administration of isosorbide
dinitrate, removal of pericardial drainage tube, and IABP
7 Pragliola C, et al. 2007 CAS after aortic valve replacement Case report Diffuse CAS, resolved with intracoronary infusion of nitrates and verapamil
8 Song MH, et al. 2006 Refractory CAS after aortic valve
replacement
Case report Multifocal RCA lesion, refractory to intracoronary infusion of nitrates and
calcium antagonists, resolved fully after ATP injection.
9 Minato N, et al. 1995 Perioperative CAS in modiﬁed Bentall's
operation for annulo-aortic ectasia in
Marfan's syndrome
Case report CAS, refractory to nitrates infusion, resolved by nicardipine
(a calcium antagonist)
10 Tsuchida K, et al. 1993 CAS after aortic valve replacement Case report Diffuse CAS, refractory to intracoronary administration of isosorbide dinitrate,
nitroglycerin, diltiazem methylprednisolone, papaverine, lidocaine, and
nifedipine through the nasogastric tube. Treated with inotropic agents,
coronary vasodilators, IABP, and deep sedation with pentobarbital.
11 Kinoshita K, et al. 1991 Perioperative CAS Retrospective
cohort study
Diverse. 1 died, 4 others responded to intravenous administration of
nitroglycerin and diltiazem ± IABP
33F. Formica et al. / IJC Heart & Vasculature 10 (2016) 32–38expected, nor did patient allude to previous occurrence of similar chest
symptom.
Laboratory ﬁndings were deranged: elevated C-reactive protein
(16.14 mg/L), and urea (30 mg/dL), with low hemoglobin (10.4 g/dL)
and platelet (120 × 109/L).
Emergent coronary angiography to probe the cause of the
hemodynamic instability conﬁrmed the diagnosis of early post-
valvular surgery multi-vessel CAS, showing over 90% spasmic occlusion
of the diagonal (D1, D2) branches of the left anterior descending (LAD)
artery, and marginal branches (M1, M2, M3) of the circumﬂex (Cx)
artery (Fig. 4).Fig. 1. Preoperative coronary angiography showed narrowing lHowever, elevated ST segment returned to baseline (Fig. 5) and CAS
progressively resolved, after infusion of intracoronary nitroglycerin in-
fusion (Fig. 6). Recovery was uneventful thereafter, and the patient
was discharged on the postoperative day 8.
3. Methods
3.1. Literature search
The PubMeddatabasewas queried for publications related to the use
of the post-valvular surgery CAS. Search was limited to human subjectsesion on ﬁrst obtuse marginal branch of circumﬂex artery.
Fig. 2. Immediate postoperative ECG showing regular sinus rhythm, no ischemic changes with good left ventricular contractility.
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entering the keywords: “coronary artery spasm,” “postoperative,” and
“valve” using the Boolean operator “or” and ‘and’, then the ﬁnal output
was reviewed for relevant English language publications. (Table 1).
Summarily the search detail was— (“coronary vasospasm”[MeSH
Terms] OR (“coronary”[All Fields] AND “vasospasm”[All Fields]) OR
“coronary vasospasm”[All Fields] OR (“coronary”[All Fields] AND
“artery”[All Fields] AND “spasm”[All Fields]) OR “coronary artery
spasm”[All Fields]) AND (“postoperative period”[MeSH Terms] OR
(“postoperative”[All Fields] AND “period”[All Fields]) OR
“postoperative period”[All Fields] OR “postoperative”[All Fields]) AND
valve[All Fields].4. Review of literature and comment
As alluded above, Post-valvular surgery CAS refers to the stimuli-
induced transient, subtotal constriction or total occlusion of some
branches of, or the entire coronary artery tree, often concomitant with
angina pectoris, with associated alteration of the ST segment onFig. 3. ECG strip showing transient a 2 mm ST segment elevation in the antelectrocardiogram (ECG) and resulting in fetal clinical outcomes, if not
adequately managed.
In this present report, through meticulous medical history review,
laboratory tests, physical examination, ECG and coronary angiography,
we promptly diagnosed and treated the patient's condition. In the con-
text of the reported clinical case, we herein review the current literature
for the clinical presentation, etiology, pathophysiology, epidemiology,
diagnosis, therapy and prognosis of post-valvular surgery CAS.4.1. Clinical presentation
Connate to the generic vasospasmic crisis, a characteristic feature of
post-valvular surgeryCAS is episodes of sudden severe restangina pectoris
associatedwith ST-segment variation andusually responsive to nitrate in-
fusion.We deliberately use the term ST-segment variation— elevation or
depression, andnot elevation asnoted in our case report and is commonly
used in classical teachings or texts [6].
ST-segment variation depends on two principal factors, amongst
others, namely, the extent of occlusion and the resultant impact oferior leads V3, V4 with similar elevation in the inferior leads II, III, aVF.
Fig. 4. Emergent coronary angiogram showing spasmic occlusion of the diagonal branches (D1) of the left anterior descending (LAD) artery andmarginal branches (OM3)of the circumﬂex
artery (Cx).
35F. Formica et al. / IJC Heart & Vasculature 10 (2016) 32–38restricted or severed blood ﬂow to the myocardial layers. Where
induced occlusion is total or near-total and sustained, there is transmural
ischemia, then occurrence of angina pectoris is accompanied by electro-
cardiographic elevation of the ST-segment. However, for partial/subtotal
occlusion or patent collateral supply, as is the case withmany CAS, ische-
mia is subendocardial or non-transmural and angina is associated with
ST-segment depression. This dynamic ST-segment — associated angina
is often with diaphoresis, syncope, nausea and/or vomiting [7]. Electro-
cardiographic alterations during CAS [8,9] are summarized below in
Table 2.Fig. 5. ECG strip showing ST segPost-valvular surgery CAS, similar to CAS of other etiologies, has
been implicated as a common cause of variant angina [2–4,10–14].
This CAS-related angina or chest pain occurs usually at rest, free from
exertion and most often late in the night [7,9,10]. This biopattern is
commonly referred to as the circadian variation and may not be
unrelated to the cyclic day-night variation in the tone of the epicardial
coronary artery — increased tone in the night/dawn, and decrease in
the day [15].
The occurrence of syncopes is not rare during CAS ischeamic
episodes [16]. These syncopes have been associated with severement returned to baseline.
Fig. 6. Coronary spasm resolution after nitroglycerin coronary infusion.Diagonal branches (D1) of the left anterior descending (LAD) artery andmarginal branches (OM3) of the circumﬂex
artery (Cx).
36 F. Formica et al. / IJC Heart & Vasculature 10 (2016) 32–38cardiac arrhythmias such as ventricular tachycardia or ﬁbrillation,
bradyarrhythmias, as well as atrioventricular block [17].
It is opined that a functional association exist between spasmic
vessel and type of arrhythmia. While left CAS is associated with
ventricular arrhythmias and elevation of the ST segment in the anterior
leads V3 and V4, right CAS is notedly associated with bradyarrhythmic
cases with acute ST-segment elevation in the inferior leads II, III, and
aVF [18].
Though the predispository mechanistic underlying still remains
unclear, there is documented association of cardiac arrhythmias with
CAS [8,19–21]. Amongst others, ventricular arrhythmia is the most
common CAS complication with sudden cardiac arrest and resultant
death [20–21]. Mechanistically, prolongation of the QT duration
with is common in syncope- or cardiac arrest-complicated variantTable 2
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As alluded to earlier, unravelling the underlying mechanism in the
causation of post-valvular surgery CAS is an ongoing process, especially
with the accumulating documentation of identiﬁed triggering factors,
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Until recently, the diagnostic holy grail for CAS, including post-
valvular surgery CAS, is demonstrated constriction (≥50%) at the site
of vessel spasm, responsive to and reversed by intracoronary infusion
of nitroglycerin [23].
In most cases, clinical diagnosis is reached based on the classical
triad of recurrent episodes of rest pain with associated ST-segment al-
teration and symptomatic response to nitrates and/or calcium channel
blockers [6].
The occurrence of postoperative coronary artery embolism (CAE) is
not a complete rarity after valvular surgery [24]. This is often secondary
to aortic cross-clamp removal, mechanical thrombectomy or decalciﬁ-
cation of ﬁbro-calciﬁed valves; while theﬁrstmay resolve spontaneous-
ly with or without speciﬁc treatment; the latter two may myocardial
revascularisation for reperfusion of affected sites. CAE should be ruled
out when the diagnosis of post-valvular surgery CAS is in consideration.
Though controversial in clinical practice [25,26], in some patients, a
‘spasm provocation test’ using stimuli like histamine, serotonin,
acetylcholine, and ergonovine, or even hyperventilation are used to
elicit spasm [27–29] and conﬁrm the clinical diagnosis of CAS.
Induced constriction less than 30% is considered normal vascular
response, however, vasoconstriction of at least 50% at the spasmic site
that is reversible with intracoronary nitroglycerin is considered a posi-
tive result [23].
It should however bementioned that the Coronary Vasomotion Dis-
orders International StudyGroup (COVADIS) after their ﬁrst symposium
held in September, 2013 to create a standardized international diagnos-
tic criteria for vasospastic angina, recommended that CAS be ‘deﬁned as
transient total or subtotal coronary artery occlusion (N 90% constriction)
with angina and ischemic ECG changes either spontaneously or in
response to a provocative stimulus (typically acetylcholine, ergot, or
hyperventilation)’ [30]. According to COVADIS, a spasm provocation
test for CAS should be considered equivocal if it does not reproduce
the usual chest pain, elicit ischemic ECG changes, and induce at least
90% vasoconstriction on angiography. The emphasis being laid on 90%
vasoconstriction, compared to the classical 50% vasoconstriction.
The consensus was that 90% vasoconstriction is the angiographic
threshold to diagnose inducible spasm. This consensus was based on
validation studies demonstrating signiﬁcantly high sensitivity and spec-
iﬁcity (N 90%) for both ergonovine and acetylcholine in the diagnosis of
spontaneous vasospasmic angina.
4.4. Epidemiology
There is a dearth of a standardized evidence-based global CAS
incidence and prevalence statistics, thus most reports are population-
speciﬁc, and highly dependent on the diagnostic criteria.
Compared to the CAS prevalence in the United States, France and
Taiwan of about 4%, 12%, and 19% respectively [31–33], the prevalence
of CAS is signiﬁcantly high (approximately 30%) in Japan [34,35], with
a large proportion being diffuse or multivessel spasm [36]. In addition,
there is divergent gender and age preponderance [37–39].
4.5. Therapy
Optimal therapeutic strategy for postoperative CAS continues to
evolve. Currently, the therapeutic agents of choice with demonstrated
efﬁcacy for CAS are long-acting nitrates and calcium channel blockers
[2–4,40–42]. Of the 11 post-valvular surgery CAS reports reviewed,
only in 2 reports were nitrates and/or calcium pump blockers found to
be ineffective (Table 1). Calcium channel blockers such as diltiazem, ni-
fedipine, verapamil, and amlodipine, either alone or in combination
with nitrates, effectively ameliorate coronary vasospasmic and angina
attack. Most spontaneous acute CAS crisis are usually responsive to
sublingual or intravenous administration of isosorbide dinitrate ornitroglycerin, however in cases as presented in our case report, where
CAS is refractory to sublingual or intravenous injection of either drugs,
intracoronary infusion proves effective. The general therapeutic trend
as noted in all 11 post-valvular surgery reports reviewed is avoidance
of non-selective β-blockers because of their ambivalent, or better put,
case-dependent effect; being beneﬁcial in atherosclerosis-associated
CAS, but detrimental in other cases, wherein via blockage of β-
adrenergic receptors, they initially mediate vasodilation, then enhance
unrestricted intravascular calcium inﬂux, and consequently result in in-
creased vasoconstriction via excitement of the α-adrenergic receptors,
thus, exacerbating the CAS crisis [43,44].
There is accumulating evidence of the beneﬁcial effect of magne-
sium, an endogenous inhibitor of calcium-entry [45], antioxidants
such as vitamin C and E [46,47], fasudil, a selective rho-kinase inhibitor
[48,49], and ﬂuvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A
reductase inhibitor [50] on the resolution of CAS.
4.6. Prognosis
Post-therapy immediate or early clinical outcome and long-term
prognosis is generally good [51,52], with a relatively low incidence of
CAS-related cardiac mortality and disease recurrence rate [53,39]. In
the context of post-valvular surgery CAS, of the total number of patients
(n=16) reported in the12 reviewed case reports, only a relativelymin-
ute 6% (n= 1) mortality due to left ventricular free wall rupture sequel
to direct cardiac massage was recorded (Table 1). Despite reported
higher CAS prevalence, the clinical outcome amongst Japanese patients
is better compared to that of their western counterparts, and this may
not be unconnected to the initiation of at least one calcium antagonist
as ﬁrst line therapy in a higher percentage of the Japanese cohort than
in the western cohort [51,52]. Cardiac events such as coronary artery
disease and acute myocardial infarction, as well as multiplicity of vessel
lesion play critical role in patient survival [51]. In addition, diminished
left ventricular ejection fraction (LVEF) has been implicated in poorer
clinical outcome and is a predictor of coronary events and all-cause
mortality [53].
In conclusion, this study while showcasing the progress made in our
generic understanding of CAS, however highlights the need for interna-
tionally standardized diagnostic guideline and therapeutic protocol, as
well as continued research of the mechanistic basis of CAS as a patho-
physiologic event.
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